Table2 Characteristics of patients according to CFP score
From: High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients
Variables | Low CFP group | High CFP group | p value |
|---|---|---|---|
Gender | 0.729 | ||
 Male | 68 (71.6) | 32 (74.4) |  |
 Female | 27 (28.4) | 11 (25.6) |  |
Age, years [median (CI)] | 60 (58–63) | 60 (56–64) | 0.899 |
Site | 0.076 | ||
 Low | 35 (36.8) | 8 (18.6) |  |
 Middle | 46 (48.4) | 28 (67.4) |  |
 Upper | 14 (14.7) | 6 (14.0) |  |
Tumor size | 0.002 | ||
  > 5 cm | 35 (36.8) | 28 (65.1) |  |
  ≤ 5 cm | 60 (63.2) | 15 (34.9) |  |
ypTNM category |  < 0.001 | ||
 0-I | 62 (65.3) | 12 (27.9) |  |
 II-III | 33 (34.7) | 31 (72.1) |  |
Histopathology (N = 129) | 0.335 | ||
 Well differentiation | 5 (5.8) | 1 (2.3) |  |
 Moderate differentiation | 74 (86.0) | 35 (81.4) |  |
 Poor differentiation | 7 (8.1) | 7 (16.3) |  |
LNH | 8.3 (7.3–9.4) | 10.0 (8.6–11.5) | 0.051 |
LVI | 0.428 | ||
 Positive | 4 (4.2) | 4 (9.3) |  |
 Negative | 91 (95.8) | 39 (90.7) |  |
PNI |  < 0.001 | ||
 Positve | 5 (5.3) | 12 (27.9) |  |
 Negative | 90 (94.7) | 31 (72.1) |  |
Tumor deposits | 0.148 | ||
 Positive | 11 (11.6) | 9 (20.9) |  |
 Negative | 84 (88.4) | 34 (79.1) |  |
TRG | 0.001 | ||
 0–1 | 64 (67.4) | 16 (37.2) |  |
 2–3 | 31(32.6) | 27 (62.8) |  |
CEA [median (CI)] | 2.6 (2.4–2.9) | 5.3 (3.9–7.1) | 0.002 |
FARI, % [median(CI)] | 7.0 (6.8–7.3) | 9.3 (8.7–9.9) |  < 0.001 |
PNI [median (CI)] | 47.4 (46.8–48.0) | 42.5 (41.4–43.5) |  < 0.001 |